FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

1 month ago 25

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.

1. Homepage
2. Brain Cancer
3. FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset